Ketamine Anesthesia for Improvement of Depression in ECT
Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this prospective randomized clinical trial is to determine if patients
receiving ketamine as a part of general anesthesia during electroconvulsive therapy (ECT)
rather than standard of care will have improvement in symptoms of depression after a course
of ECT treatments. The investigators hypothesize that utilization of ketamine for induction
of general anesthesia during ECT treatments will improve symptoms of depression better than
standard care.
This study is ONLY open to patients eligible to receive healthcare services through the
Department of Veterans Affairs at the VA Puget Sound, which means service in the active
military, naval or air service or separation under any condition other than dishonorable.
Qualifications for VA health care benefits can be found at va.gov.